CDEK
← All drugs Report issue

rhizoma atractylodis macrocephalae

Botanicalexperimental

Clinical trial activity

11 trials · 30 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
6
Phase 3
1
Phase 4
0

Earliest trial started Nov 1, 2000 (NCT00393510)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • rhizoma atractylodis macrocephalae
  • rhizoma atractylodis marcocephalae

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06703788Phase 1/Phase 2 (Phase 2)Nov 20, 2024Chang Gung University, Government of Taiwan
NCT06860763N/AOct 15, 2024Mahidol University, Peking University
NCT05360004Phase 2May 31, 2022Hong Kong Baptist University
NCT05269511N/AMar 10, 2022Hong Kong Baptist University
NCT03577938N/ASep 1, 2018Capital Medical University, China Medical University, Fudan University, Fuzhou Infectious Hospital, Government of China, Guangxi Medical University, Hangzhou Xixi hospital, Henan Medical University, Hepatobiliary Disease Hospital of Jilin Province, Jilin, China, Huazhong University of Science and Technology, Hubei University of Chinese Medicine, Hunan University of Traditional Chinese Medicine, Jilin University, People's Liberation Army of China, Shanghai University of Traditional Chinese Medicine, Shenzhen Third People's Hospital, Shenzhen University, Sun Yat-Sen University, Xiamen University
NCT02194946Phase 1/Phase 2 (Phase 2)Jul 1, 2014Government of China, Guangdong Provincial Hospital of Traditional Chinese Medicine, Peking University
NCT01613183N/AMay 31, 2012China Academy of Chinese Medical Sciences
NCT01441752Phase 3Nov 1, 2011Shanghai University of Traditional Chinese Medicine
NCT01745328N/AJan 1, 2009Beijing Institute of Disease Control and Prevention
NCT00856167Phase 2Sep 1, 2006National Center for Complementary and Integrative Health (NCCIH), University of Arizona
NCT00393510Phase 2Nov 1, 2000Chinese University of Hong Kong
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (30)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment2022014
Hong Kong Baptist UniversityAcademic/Hospital2222022
Peking UniversityAcademic/Hospital2122014
Shanghai University of Traditional Chinese MedicineAcademic/Hospital2122011
Beijing Institute of Disease Control and PreventionAcademic/Hospital1112009
Capital Medical UniversityAcademic/Hospital1012018
Chang Gung UniversityAcademic/Hospital1112024
China Academy of Chinese Medical SciencesAcademic/Hospital1112012
China Medical UniversityAcademic/Hospital1012018
Chinese University of Hong KongAcademic/Hospital1112000
Fudan UniversityAcademic/Hospital1012018
Fuzhou Infectious HospitalAcademic/Hospital1012018
Government of TaiwanGovernment1012024
Guangdong Provincial Hospital of Traditional Chinese MedicineAcademic/Hospital1112014
Guangxi Medical UniversityAcademic/Hospital1012018
Hangzhou Xixi hospitalAcademic/Hospital1012018
Henan Medical UniversityAcademic/Hospital1012018
Hepatobiliary Disease Hospital of Jilin Province, Jilin, ChinaAcademic/Hospital1012018
Huazhong University of Science and TechnologyAcademic/Hospital1012018
Hubei University of Chinese MedicineAcademic/Hospital1012018
30 organizations
Page 1 / 2